Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1627281 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.86Day +0.70%1Y +2.0%Off 52W high −47.8%Vol (1Y) 78.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,851 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.4% of sh out |
| Days to cover16.8d |
| 13F net flow (QoQ)−0.40% |
| Top-10 13F concentration98.5% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$79.6M |
| Earnings (TTM)-$67.6M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−40.9% |
| 1Y+2.0% |
| 3Y+33.6% |
| 5Y−78.5% |
| 10Y−89.2% |
| Since incept. (ann.)−20.6% |
Total return through 2026-07-29 · series begins 2015-03-25. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)78.4% |
| Ann. volatility (3Y)126.1% |
| Sharpe (1Y)0.39 |
| Sharpe (3Y)0.49 |
| Max drawdown (1Y)−51.4% |
| Max drawdown (3Y)−67.6% |
| Beta (3Y vs SPY)4.56 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| B Group, Inc. | 3.3M | $10M | — | +0.0% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.2M | $10M | — | +0.0% |
| Long Focus Capital Management, LLC | 2.7M | $9M | — | −1.6% |
| BlackRock, Inc. | 341,523 | $1M | — | −11.1% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 226,875 | $719,000 | — | +0.0% |
| MORGAN STANLEY | 86,776 | $275,080 | — | −0.5% |
| LPL Financial LLC | 84,345 | $267,374 | — | −0.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 65,942 | $209,036 | — | +25.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for CLLS.
